Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director
Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased to announce the appointment of Thurein Htoo as the new Chairman of the Board...
Pathcore Announces Partnership With Fortelinea to Accelerate Adoption of Digital Pathology and Streamline Digital Review of Slides
Pathcore Inc., a leader in digital pathology software solutions, is excited to announce a partnership with Fortelinea Software Systems, an innovative provider of histology tracking...
Pathcore Announces Strategic Partnership With Instem to Enhance Digital Pathology Solutions for Toxicologic Pathology Workflows
Pathcore Inc., a leader in digital pathology software solutions, is pleased to announce a strategic partnership with Instem, a leading provider of IT solutions and...
Humonix Biosciences Appoints Karen Torrejon, PhD, as New Chief Executive Officer
Dr. Torrejon, the original founder of Humonix, replaces Kimberly Southern Humonix Biosciences, Inc. (“Humonix”), a specialty pharmaceutical research company focused on 3D human tissue models...
RevContent Promotes Matt Hoy to Chief Revenue Officer
RevContent, a leading content marketing and native advertising platform, today announced Matt Hoy will serve as its next Chief Revenue Officer. Hoy, who has been...
Humonix Biosciences Launches New 3D Human Tissue Model
Specialty pharmaceutical research company’s new retinal vascular dysfunction model can have a major impact on research and development of new drugs for retinal vascular diseases....
Pathcore and StageBio Announce a Strategic Partnership to Revolutionize the Pathology Laboratory
StageBio, a leading provider of histology, pathology, image analysis, specimen archiving and biorepository services, is pleased to announce a strategic partnership with Pathcore, an innovative...
Glauconix is Now Humonix | Newswire
Specialty pharmaceutical research company celebrates the launch of a new service offering and with it, a brand refresh. Glauconix Biosciences, Inc. is now Humonix Biosciences,...
AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio
AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies. AmplifyBio, an...
D2V Clinical: Raising the Bar for Early-Phase Oncology
Dose2Value Clinical (D2V Clinical) is a full-service global CRO addressing the challenges of early-phase oncology studies faced by biotech companies. Founded by seasoned veterans from...